A novel multilayered multidisk oral tablet for chronotherapeutic drug delivery

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Khan, Zaheeda ^a   Choonara, Yahya E ^a   Kumar, Pradeep ^a   Du Toit, Lisa C ^a   Ndesendo, Valence M K ^b   Pillay, Viness ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b ST JOHN'S UNIVERSITY OF TANZANIA   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; DILTIAZEM; ETHYL CELLULOSE; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; THEOPHYLLINE; 2 ETHOXYETHANOL; 2-ETHOXYETHANOL; CELLULOSE; DRUG DERIVATIVE; ETHYLENE GLYCOL DERIVATIVE; METHYLCELLULOSE; PECTIN; POLYMER; TABLET;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BACK PROPAGATION; CHRONOTHERAPY; CONTROLLED STUDY; DELAYED DRUG RELEASE; DIELECTRIC CONSTANT; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HUMAN; IN VITRO STUDY; MOLECULAR MECHANICS; MULTILAYERED MULTIDISK TABLET; PERCEPTRON; POLYMERIZATION; TABLET; ULTRAVIOLET SPECTROPHOTOMETRY; WATER TRANSPORT; CHEMISTRY; KINETICS; ADMINISTRATION AND DOSAGE; ANALOGS AND DERIVATIVES;

CELLULOSE; DILTIAZEM; DRUG CHRONOTHERAPY; DRUG DELIVERY SYSTEMS; ETHYLENE GLYCOLS; HUMANS; KINETICS; METHYLCELLULOSE; PECTINS; POLYMERS; TABLETS; HYPROMELLOSE DERIVATIVES;

EID: 84884259531     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/569470     Document Type: Article

References (47)

1. Bahammam A., Alrajeh M., Albabtain M., Bahammam S., Sharif M., Circadian pattern of sleep, energy expenditure, and body temperature of young healthy men during the intermittent fasting of Ramadan. Appetite 2010 54 2 426 429 2-s2.0-76949094507 10.1016/j.appet.2010.01.011
2. Hsieh C.-H., Ohman M. D., Biological responses to environmental forcing: the linear tracking window hypothesis. Ecology 2006 87 8 1932 1938 2-s2.0-33747055992
3. Reddy A. B., O'Neill J. S., Healthy clocks, healthy body, healthy mind. Trends in Cell Biology 2010 20 1 36 44 2-s2.0-72549118386 10.1016/j.tcb.2009.10. 005
4. Rosenwasser A. M., Circadian clock genes: non-circadian roles in sleep, addiction, and psychiatric disorders? Neuroscience and Biobehavioral Reviews 2010 34 8 1249 1255 2-s2.0-77954083602 10.1016/j.neubiorev.2010.03.004
5. Sewlall S., Pillay V., Danckwerts M. P., Choonara Y. E., Ndesendo V. M. K., du Toit L. C., A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Current Drug Delivery 2010 7 5 370 388 2-s2.0-79955025126
6. Burioka N., Sako T., Tomita K., Miyata M., Suyama H., Igishi T., Shimizu E., Theophylline chronotherapy of nocturnal asthma using bathyphase of circadian rhythm in peak expiratory flow rate. Biomedicine and Pharmacotherapy 2000 55 1 142 146 2-s2.0-10644268721
7. Hermida R. C., Ayala D. E., Fernández J. R., Calvo C., Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 2008 51 1 69 76 2-s2.0-37349007842 10.1161/HYPERTENSIONAHA.107.096933
8. Cutolo M., Seriolo B., Craviotto C., Pizzorni C., Sulli A., Circadian rhythms in RA. Annals of the Rheumatic Diseases 2003 62 7 593 596 2-s2.0-0038208315 10.1136/ard.62.7.593
9. Douglas J. G., Compliance with antihypertensive therapy: is it time for chronotherapy? American Journal of Hypertension 2002 15, article A238
10. Hassan A., Haefeli W. E., Appropriateness of timing of drug administration in electronic prescriptions. Pharmacy World and Science 2010 32 2 162 171 2-s2.0-77953324387 10.1007/s11096-009-9362-4
11. Kraft M., Martin R. J., Chronobiology and chronotherapy in medicine. Disease-a-Month 1995 41 8 506 575 2-s2.0-0029353588
12. Lévi F., Circadian chronotherapy for human cancers. Lancet Oncology 2001 2 5 307 315 2-s2.0-0035353082 10.1016/S1470-2045(00)00326-0
13. Lemmer B., The importance of circadian rhythms on drug response in hypertension and coronary heart disease-from mice and man. Pharmacology and Therapeutics 2006 111 3 629 651 2-s2.0-33746694167 10.1016/j.pharmthera.2005.11. 008
14. Mastiholimath V. S., Dandagi P. M., Jain S. S., Gadad A. P., Kulkarni A. R., Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. International Journal of Pharmaceutics 2007 328 1 49 56 2-s2.0-34547653365 10.1016/j.ijpharm.2006.07.045
15. Prisant L. M., Hypertension and chronotherapy: shifting the treatment paradigm. American Journal of Hypertension 2001 14 9 277 279 2-s2.0-0034834792
16. Sher P., Ingavle G., Ponrathnam S., Pawar A. P., Low density porous carrier based conceptual drug delivery system. Microporous and Mesoporous Materials 2007 102 1-3 290 298 2-s2.0-34247138920 10.1016/j.micromeso.2007.01. 001
17. Smith D. H. G., Pharmacology of cardiovascular chronotherapeutic agents. American Journal of Hypertension 2001 14 9 296 301 2-s2.0-0034827029
18. Smolensky M. H., Portaluppi F., Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. American Heart Journal 1999 137 4 S14 S24 2-s2.0-0032939190
19. Sutherland E. R., Nocturnal asthma. Journal of Allergy and Clinical Immunology 2005 116 6 1179 1187 2-s2.0-28444440914 10.1016/j.jaci.2005.09.028
20. Youan B.-B. C., Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? Journal of Controlled Release 2004 98 3 337 353 2-s2.0-4143114457 10.1016/j.jconrel.2004.05.015
21. Dashevsky A., Mohamad A., Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat ECD. International Journal of Pharmaceutics 2006 318 1-2 124 131 2-s2.0-33745481506 10.1016/j.ijpharm.2006.03.022
22. Kalantzi L. E., Karavas E., Koutris E. X., Bikiaris D. N., Recent advances in oral pulsatile drug delivery. Recent Patents on Drug Delivery and Formulation 2009 3 1 49 63 2-s2.0-60849118657 10.2174/187221109787158337
23. Kumar K. P. S., Bhowmik D., Chandira C. M., Tripathi K. K., Innovations in sustained release drug delivery system and its market opportunities. Journal of Chemical and Pharmaceutical Research 2010 2 1 349 360
24. Lemmer B., Circadian rhythms and drug delivery. Journal of Controlled Release 1991 16 1-2 63 74 2-s2.0-0025762076
25. Fan T. Y., Wei S. L., Yan W. W., Chen D. B., Li J., An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets. Journal of Controlled Release 2001 77 3 245 251 2-s2.0-0035856763 10.1016/S0168-3659(01) 00508-9
26. Iskakov R. M., Kikuchi A., Okano T., Time-programmed pulsatile release of dextran from calcium-alginate gel beads coated with carboxy-n-propylacrylamide copolymers. Journal of Controlled Release 2002 80 1-3 57 68 2-s2.0-0037161340 10.1016/S0168-3659(01)00551-X
27. Kadam V. D., Gattani S. G., Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma. Drug Delivery 2010 17 5 343 351 2-s2.0-77953262236 10.3109/10717541003762821
28. Krögel I., Bodmeier R., Floating or pulsatile drug delivery systems based on coated effervescent cores. International Journal of Pharmaceutics 1999 187 2 175 184 2-s2.0-0345035517 10.1016/S0378-5173(99)00189-1
29. Lin H.-L., Lin S.-Y., Lin Y.-K., Ho H.-O., Lo Y.-W., Sheu M.-T., Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling. European Journal of Pharmaceutics and Biopharmaceutics 2008 70 1 289 301 2-s2.0-50149114921 10.1016/j.ejpb.2008.03.021
30. Schellekens R. C. A., Stellaard F., Mitrovic D., Stuurman F. E., Kosterink J. G. W., Frijlink H. W., Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings. Journal of Controlled Release 2008 132 2 91 98 2-s2.0-56349131665 10.1016/j.jconrel.2008.08.008
31. Li B., Zhu J., Zheng C., Gong W., A novel system for three-pulse drug release based on "tablets in capsule" device. International Journal of Pharmaceutics 2008 352 1-2 159 164 2-s2.0-39449123888 10.1016/j.ijpharm.2007. 10.043
32. Bussemer T., Dashevsky A., Bodmeier R., A pulsatile drug delivery system based on rupturable coated hard gelatin capsules. Journal of Controlled Release 2003 93 3 331 339 2-s2.0-0242322512 10.1016/j.jconrel.2003.08.012
33. Efentakis M., Koligliati S., Vlachou M., Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release. International Journal of Pharmaceutics 2006 311 1-2 147 156 2-s2.0-33644623330 10.1016/j.ijpharm.2005.12.026
34. Ghimire M., McInnes F. J., Watson D. G., Mullen A. B., Stevens H. N. E., In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog. European Journal of Pharmaceutics and Biopharmaceutics 2007 67 2 515 523 2-s2.0-34547697319 10.1016/j.ejpb.2007.03.002
35. Sungthongjeen S., Puttipipatkhachorn S., Paeratakul O., Dashevsky A., Bodmeier R., Development of pulsatile release tablets with swelling and rupturable layers. Journal of Controlled Release 2004 95 2 147 159 2-s2.0-1242331818 10.1016/j.jconrel.2003.10.023
36. Sharma S., Pawar A., Low density multiparticulate system for pulsatile release of meloxicam. International Journal of Pharmaceutics 2006 313 1-2 150 158 2-s2.0-33645321628 10.1016/j.ijpharm.2006.02.001
37. Smolensky M. H., Lemmer B., Reinberg A. E., Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Advanced Drug Delivery Reviews 2007 59 9-10 852 882 2-s2.0-35148824741 10.1016/j.addr.2007.08.016
38. Smolensky M. H., D'Alonzo G. E., Biologic rhythms and medicine. American Journal of Medicine 1988 85 1 34 46 2-s2.0-0023688443
39. Lee S. S., Lim C. B., Pai C. M., Lee S. P., Seo M. G., Park H., Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides. US Patent 6, 413.494, 1999
40. Giannola L. I., De Caro V., Giandalia G., Siragusa M. G., Tripodo C., Florena A. M., Campisi G., Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design. European Journal of Pharmaceutics and Biopharmaceutics 2007 67 2 425 433 2-s2.0-34547678148 10.1016/j.ejpb.2007.02.020
41. Pillay V., Fassihi R., Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. Journal of Controlled Release 1998 55 1 45 55 2-s2.0-0031723063 10.1016/S0168-3659(98)00022-4
42. Efentakis M., Vlachou M., Evaluation of high molecular weight poly(oxyethylene) (Polyox)polymer: studies of flow properties and release rates of furosemide and captopril from controlled-release hard gelatin capsules. Pharmaceutical Development and Technology 2000 5 3 339 346 2-s2.0-0033853233 10.1081/PDT-100100549
43. Kumar P., Pillay V., Choonara Y. E., Modi G., Naidoo D., du Toit L. C., In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. International Journal of Molecular Sciences 2011 12 1 694 724 2-s2.0-79251636605 10.3390/ijms12010694
44. Pillay V., Fassihi R., Electrolyte-induced compositional heterogeneity: a novel approach for rate-controlled oral drug delivery. Journal of Pharmaceutical Sciences 1999 88 11 1140 1148 2-s2.0-0032720381 10.1021/js9901054
45. Pillay V., Fassihi R., In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. I. Comparison of pH-responsive drug release and associated kinetics. Journal of Controlled Release 1999 59 2 229 242 2-s2.0-0032898269 10.1016/S0168-3659(98) 00196-5
46. Tiller A. R., Gorella B., Estimation of polymer compatibility from molecular mechanics calculations. Polymer 1994 35 15 3251 3259 2-s2.0-0028468124
47. Pérez S., Kouwijzer M., Mazeau K., Engelsen S. B., Modeling polysaccharides: present status and challenges. Journal of Molecular Graphics 1996 14 6 307 321 2-s2.0-0030422861 10.1016/S0263-7855(97)00011-8